396 related articles for article (PubMed ID: 3373218)
1. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R
J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218
[TBL] [Abstract][Full Text] [Related]
2. Effects of aging on nicotinic and muscarinic autoreceptor function in the rat brain: relationship to presynaptic cholinergic markers and binding sites.
Araujo DM; Lapchak PA; Meaney MJ; Collier B; Quirion R
J Neurosci; 1990 Sep; 10(9):3069-78. PubMed ID: 2398371
[TBL] [Abstract][Full Text] [Related]
3. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.
Aubert I; Araujo DM; Cécyre D; Robitaille Y; Gauthier S; Quirion R
J Neurochem; 1992 Feb; 58(2):529-41. PubMed ID: 1729398
[TBL] [Abstract][Full Text] [Related]
4. Effect of chronic nicotine treatment on nicotinic autoreceptor function and N-[3H]methylcarbamylcholine binding sites in the rat brain.
Lapchak PA; Araujo DM; Quirion R; Collier B
J Neurochem; 1989 Feb; 52(2):483-91. PubMed ID: 2911027
[TBL] [Abstract][Full Text] [Related]
5. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease.
Lange KW; Wells FR; Jenner P; Marsden CD
J Neurochem; 1993 Jan; 60(1):197-203. PubMed ID: 8417140
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.
Kellar KJ; Whitehouse PJ; Martino-Barrows AM; Marcus K; Price DL
Brain Res; 1987 Dec; 436(1):62-8. PubMed ID: 3690354
[TBL] [Abstract][Full Text] [Related]
7. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.
Shimohama S; Taniguchi T; Fujiwara M; Kameyama M
J Neurochem; 1986 Jan; 46(1):288-93. PubMed ID: 3940287
[TBL] [Abstract][Full Text] [Related]
8. Characterization of N-[3H]methylcarbamylcholine binding sites and effect of N-methylcarbamylcholine on acetylcholine release in rat brain.
Araujo DM; Lapchak PA; Collier B; Quirion R
J Neurochem; 1988 Jul; 51(1):292-9. PubMed ID: 3379410
[TBL] [Abstract][Full Text] [Related]
9. Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain.
Aubert I; Cécyre D; Gauthier S; Quirion R
J Comp Neurol; 1996 May; 369(1):31-55. PubMed ID: 8723701
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
Cortés R; Probst A; Tobler HJ; Palacios JM
Brain Res; 1986 Jan; 362(2):239-53. PubMed ID: 3753655
[TBL] [Abstract][Full Text] [Related]
11. 192IGG-saporin-induced selective lesion of cholinergic basal forebrain system: neurochemical effects on cholinergic neurotransmission in rat cerebral cortex and hippocampus.
Rossner S; Schliebs R; Härtig W; Bigl V
Brain Res Bull; 1995; 38(4):371-81. PubMed ID: 8535860
[TBL] [Abstract][Full Text] [Related]
12. Colchicine administered into the area of the nucleus basalis decreases cortical nicotinic cholinergic receptors labelled by [3H]-acetylcholine.
Tilson HA; Schwartz RD; Ali SF; McLamb RL
Neuropharmacology; 1989 Aug; 28(8):855-61. PubMed ID: 2779754
[TBL] [Abstract][Full Text] [Related]
13. Multiple cholinergic markers are unexpectedly not altered in the rat dentate gyrus following entorhinal cortex lesions.
Aubert I; Poirier J; Gauthier S; Quirion R
J Neurosci; 1994 May; 14(5 Pt 1):2476-84. PubMed ID: 8182423
[TBL] [Abstract][Full Text] [Related]
14. Neocortical cholinergic enzyme and receptor activities in the human fetal brain.
Perry EK; Smith CJ; Atack JR; Candy JM; Johnson M; Perry RH
J Neurochem; 1986 Oct; 47(4):1262-9. PubMed ID: 3746300
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic markers in aged cognitively impaired Long-Evans rats.
Aubert I; Rowe W; Meaney MJ; Gauthier S; Quirion R
Neuroscience; 1995 Jul; 67(2):277-92. PubMed ID: 7675169
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic and nicotinic receptor changes in the cortex and thalamus of brains of chronic alcoholics.
Hellström-Lindahl E; Winblad B; Nordberg A
Brain Res; 1993 Aug; 620(1):42-8. PubMed ID: 8402197
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic cholinergic receptor subtypes in normal human brain and Alzheimer's presenile dementia.
Vanderheyden P; Ebinger G; Dierckx R; Vauquelin G
J Neurol Sci; 1987 Dec; 82(1-3):257-69. PubMed ID: 3440867
[TBL] [Abstract][Full Text] [Related]
18. Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies.
Flynn DD; Weinstein DA; Mash DC
Ann Neurol; 1991 Mar; 29(3):256-62. PubMed ID: 2042942
[TBL] [Abstract][Full Text] [Related]
19. Regional distribution of muscarinic and nicotinic cholinergic receptor binding activities in the human brain.
Perry EK; Smith CJ; Perry RH; Whitford C; Johnson M; Birdsall NJ
J Chem Neuroanat; 1989; 2(4):189-99. PubMed ID: 2597358
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic receptor plasticity in rats lesioned in the nucleus basalis of Meynert.
Vige X; Briley M
Neuropharmacology; 1989 Jul; 28(7):727-32. PubMed ID: 2761681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
